Catheter Precision awards 700,000 incentive stock options to CEO and CCO at $0.42

Catheter Precision, Inc.

CEO David Jenkins received options for 450,000 shares; 90,000 vested immediately, 120,000 vest each Jan 2026–2028.
CCO Marie-Claude Jacques received 250,000 options: half time-vesting over 5 years, half performance-vesting based on Q1–Q4 2025 sales targets.
Exercise price $0.42 per share; 10-year term; granted under the 2023 Executive Incentive Plan.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.